006.06.21 Ark. Code R. 005

Current through Register Vol. 49, No. 10, October, 2024

Rule 006.06.21-005 - Thoroughbred Rule 1232(5) Medication Furosemide (Lasix)

1232.MEDICATION: FUROSEMIDE (LASIX)

* * * *

(5) The franchise holder may prohibit the administration of furosemide to horses entered in the following races, by so stating in the conditions of the race:

(a) a stakes race, including races designated as graded stakes by the American Graded Stakes Committee of the Thoroughbred Owners and Breeders Association or its successor, as necessary for the stakes race to remain eligible for graded status; and

(b) races for horses three (3) years of age, as necessary for horses participating in the race to be entitled to accumulate points based on their performance in the race for eligibility ranking to run in the Kentucky Derby and Kentucky Oaks.

If the franchise holder so prohibits the administration of furosemide to horses entered in any of the above-referenced races, such race shall be referred to as a "Lasix-free Race." With respect to any horse participating in a Lasix-free Race, it shall constitute a violation of this Rule 1232(5) if the horse's post-race sample of urine, serum or plasma tests positive for furosemide at any level of detection indicating use within the 48-hour period prior to the Lasix-free Race. Such violation shall be deemed to constitute violation under Penalty Category "B" of the ARCI Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule set forth in Rule 1217.5 in the Appendix to these Rules, with resulting consequences and penalties to the horse, owner and trainer as set forth therein for Penalty Category "B" violations.

006.06.21 Ark. Code R. 005

Adopted by Arkansas Register Volume MMXXI Number 12, Effective 11/30/2021